fda warning letters compounded semaglutide tirzepatide 2025 issues 30 to online GLP-1 compounders FDA says 'no clinical need'

Hair shedding linked to GLP-1 use is usually telogen effluvium, a temporary shift in the hair growth cycle that often improves once weight stabilizes and nutrient needs are met

A multidisciplinary team gives best results

[DOI] [PMC free article] [PubMed] [Google Scholar] 35.Dragonieri S., Portacci A., Quaranta V.N., Carratu P., Lazar Z., Carpagnano G.E., Bikov A

After clinical trials are completed, regulatory authorities review the available evidence on safety and effectiveness before deciding whether a treatment can become widely available

Pricing reflects bundled care including physician-supervised medical care, treatment management, ongoing clinical support, and compounded medication when prescribed